Christopher R. Fenimore
Executive VP of Finance & CFOMr. Christopher R. Fenimore, also known as Chris, CPA, serves as its Executive Vice President of Finance at Regeneron Pharmaceuticals, Inc. He had been Controller at Regeneron Pharmaceuticals, Inc. since March 2017 until February 2024 and had been its Senior Vice President and serves as its Chief Financial Officer from February 5, 2024 and served as its Head of Accounting since January 2021 until 2024. Mr. Fenimore served as Vice President at Regeneron Pharmaceuticals, Inc. since January 2017 until January 2021. He served as Vice President of Financial Planning at Regeneron Pharmaceuticals, Inc. from January 2012 to December 2016. From January 2017 to March 2017, he served as Vice President and Deputy Controller at Regeneron. Prior to joining the Company in 2003, Mr. Fenimore served as Vice President at Needham & Company, LLC. He served as the Vice President of Finance at Mojave Therapeutics, Inc. He joined Mojave in March 2001. He was previously at CW Group. At CW Group, Mr. Fenimore was responsible for evaluating new investment opportunities and providing strategic and financial advice to portfolio companies. He served as Vice President of CW Ventures III, L.P. Prior to working at CW Group, Mr. Fenimore was a Vice President in the Healthcare Corporate Finance Group of Needham and Company, Inc. At Needham, Mr. Fenimore executed a range of transactions consisting of initial public offerings, secondary offerings, private placements, mergers and acquisitions. Mr. Fenimore's prior experience includes working as a supervising senior accountant at KPMG, as well as healthcare industry-focused venture capital and investment banking roles. Mr. Fenimore is a Certified Public Accountant in the State of New York. Mr. Fenimore holds an M.A. in Biotechnology from Columbia University, an M.B.A. in Professional Accounting from Rutgers Business School and a B.A. in Economics from Rutgers University.
Positions
- Company NameRegeneron Pharmaceuticals, Inc.Stock CodeREGNPositionExecutive VP of Finance & CFOColleagues
- LSLeonard S. SchleiferCo-Founder, President, CEO & Co-Chairman
- GDGeorge D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman
- JJJoseph J. LaRosaExecutive VP, General Counsel & Secretary
- AJAndrew J. MurphyExecutive VP of Research & Co-Chief Scientific Officer
- GLGeorge L. SingIndependent Director
- CAChristine Ann PoonLead Independent Director
- JLJoseph L. GoldsteinIndependent Director
